总时间（秒）：10.69
问答时间（秒）：8.89

```json
{
  "Variants Include": [
    {
      "Gene": "SYN1",
      "variants": [
        {
          "HGVS": "NM_001044772.3:c.1249A>G",
          "cDNA Change": {
            "transcript": "NM_001044772.3",
            "ref": "A",
            "alt": "G",
            "position": "1249"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "R",
            "position": "417"
          },
          "Description in input context": "The substitution of R417 with R results in a stable protein conformation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson’s Disease",
    "MONDO": "MONDO:0003633"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunoprecipitation followed by Western Blotting",
      "Material used": {
        "Material Source": "Transgenic mice",
        "Material Name": "APP/PS1 double transgenic mice",
        "Description": "Mice expressing human APP and PS1 were used to model PD pathology"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001044772.3:c.1249A>G",
          "Conclusion": "Increased",
          "Molecular Effect": "Dominant Negative Effect",
          "Result Description": "The A1249G variant was associated with increased α-synuclein aggregation in APP/PS1 double transgenic mice, resulting in elevated levels of α-synuclein in the brain."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent groups of mice were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was performed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "No positive control was included"
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No negative control was included"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student’s t-test"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Immunoprecipitation followed by Western Blotting is a common method for studying α-synuclein aggregation and function in Parkinson’s disease research."
      }
    }
  ]
}
```